[The course of patients treated with placebo in trials of maintenance treatment of rheumatoid arthritis. Consequences for phase II studies].
Méry
C
C
Clinique de Rhumatologie, Hôpital Cochin, Paris.
George
N
N
de Géry
A
A
Job-Deslandre
C
C
Menkès
C J
CJ
Amor
B
B
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004341:Drug Evaluation / Q000379:methods*; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D015990:Placebo Effect; D010919:Placebos; D012189:Retrospective Studies; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D010919:Placebos
Evolution des malades traités par placebo dans les essais de traitements de fond de la polyarthrite rhumatoïde. Conséquences pour les études de phase II.